nForming Stem Cell Therapy Market Smart Book

The nForming Stem Cell Therapy Market Smart Books offer a comprehensive compilation of data pertaining to historical revenue, user volume, prices, and other relevant information for each segment. This includes products and services, type of indication, age group, and detailed analysis of service providers with coverage at both regional and country levels. The data spans the past three years and provides projections up until 2030. The smart book also provides extensive information on the leading suppliers and their corresponding market shares in the stem cell therapy market. The stem cell therapy market comprises a range of qualitative factors, including significant growth drivers, opportunities, and challenges.

Stem Cell Therapy Market: Recent Developments 

The stem cell therapy industry is seeing a variety of developments. Among the major development areas are:

• Recent Developments

  • In April 2023, Omisirge (omidubicel-onlv), a significantly altered allogeneic (donor) cord blood-based cell treatment, was approved by the US FDA.

• • In April 2022, PromoCell declared the “PromoExQ MSC Growth Medium XF” available for use in cell therapy manufacturing. The xeno- and serum-free medium has been optimised for the in-vitro development of human MSCs in a GMP-regulated environment, providing consistent growth and maintenance of different types of multipotent MSCs. It complies with the company’s EXCiPACT GMP certification process.

Read more opportunities in the stem cell therapy market in the Smart Book.

Stem Cell Therapy Market Drivers

Growing stem cell treatment research and development initiatives to drive market growth

The market for stem cell therapy is expanding significantly due to growing stem cell treatment research and development initiatives. Over the course of the forecast period, one of the key drivers projected to propel growth in the stem cell treatment market is the industry players’ increased research and development efforts. For example, in July 2018, the Marcus Foundation awarded a US$ 13 million grant to the Emory Orthopaedics & Spine Centre, with which they then collaborated with Sanford Health, Duke University, the Andrews Institute, and the Georgia Institute of Technology to conduct a multicentre clinical trial investigating stem cell options for treating osteoarthritis. The Phase 3 trial was scheduled to conclude by December 2021, but it started in March 2019.

Stem Cell Therapy Market: Restraints

Technical restrictions hinder market growth.

A significant barrier to the expansion of the stem cell therapy industry is the technical restrictions. It becomes challenging for a manufacturer to scale up production due to technological challenges encountered at several manufacturing phases, such as stem cell identification, isolation, storage, and preservation. Large-scale stem cell production is anticipated to be hampered by limited manufacturing capacity for production scale-up. The research phase’s development process has an impact on the scaling-up process as well. The cost of production scaling and its scalability are typically given less consideration. For proliferation and differentiation, different stem cells require diverse habitats. These environments may include flow or mechanical stimulation, varying gas pressures, chemical gradients, three-dimensional frameworks, and paracrine signalling from supporting cells. These elements depend on the kind and source of the stem cells.

Read all the major drivers and trends of the stem cell therapy market in the Smart Book.

Stem Cell Therapy Market: Regional Landscape

North America dominated the Stem Cell Therapy market in 2022

The region’s market products are now more widely accepted due to the presence of innovators and important market participants. Due to its robust biotechnology sector, the presence of major firms, its significant R&D, and its promotion of customized medications, North America leads the market. The largest revenue share is attributed to the region. Furthermore, the growing government initiative to promote stem cell therapy is another factor contributing to the increase in this region. For example, the Canadian government committed over USD 7 million to stem cell and regenerative medicine research in March 2020. To help the nation’s regenerative medicine industry flourish, it will fund four clinical studies and nine international ventures.

Read more competitive developments in the Stem Cell Therapy Market Smart Book.

Global Stem Cell Therapy Market: Key Companies

• Advanced Cell Technology, Inc.
• STEMCELL Technologies Inc.
• Cellular Engineering Technologies Inc.
• CellGenix GmbH   
• PromoCell GmbH
• Kite Pharma
• Lonza
• Cellartis AB
• Angel Biotechnology
• Brainstorm Cell Therapeutics
• Celgene Corporation
• Osiris Therapeutics
• Genea Biocells
• Bioheart Inc.
• Waisman Biomanufacturing
• Tigenix
• Caladrius Biosciences
• Gamida Cell.

Stem Cell Therapy Market Segmentation:

The global stem cell therapy market has been segmented into type, cell source, and therapeutic application.

Based on type, allogeneic stem cell therapy and autologous stem cell therapy are segments of the global stem cell therapy market. The allogeneic stem cell therapy segment dominated the market in 2022. since it gives patients a new immune system when the receiver engrafts donor cells. Allogeneic stem cell transplantation can treat a wide range of malignant and non-cancerous illnesses, including acute and chronic leukaemia, Hodgkin’s lymphoma, adrenoleukodystrophy, and bone marrow failure syndromes.

Based on cell source, the market is classified into adipose tissue-derived MSCS (mesenchymal stem cells), bone marrow-derived MSCS, placental/umbilical cord-derived MSCS, and other cell sources. In 2022, the adipose tissue-derived MSCs (mesenchymal stem cells) category dominated the global market. Due to the increasing use of these MSCs in a variety of medicinal applications. Additionally, the market for placental cord-derived stem cells is anticipated to develop in the upcoming years due to increased study and use of these cells.

Based on therapeutic applications, the market is classified into musculoskeletal disorders, wounds & surgeries, cardiovascular diseases, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications. In 2022, the musculoskeletal disorders category dominated the global market. Some of the key reasons propelling the segmental expansion are the rising prevalence of musculoskeletal conditions like osteoarthritis and the expanding need for regenerative medicine in orthopaedic and sports medicine applications.

Segmentation: